Dermata Therapeutics, Inc. Human Resources Contracts & Agreements
20 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Consulting Agreements (2)
- Employment Agreements (12)
- Third Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on May 7, 2024)
- Second Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on August 3, 2023)
- Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri K. Van Hoose (Filed With SEC on March 13, 2023)
- Amendment No. 3 dated July 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher Nardo (Filed With SEC on August 15, 2022)
- Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri K. Van Hoose (Filed With SEC on February 4, 2022)
- Amendment No. 1 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera, Ph.D (Filed With SEC on February 4, 2022)
- Amendment No. 2 dated January 1, 2022 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo (Filed With SEC on February 4, 2022)
- Amendment dated December 6, 2021 to the Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo dated August 17, 2021 (Filed With SEC on December 10, 2021)
- Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera dated December 6, 2021 (Filed With SEC on December 10, 2021)
- Employment Agreement by and between Dermata Therapeutics, Inc. and Kyri Van Hoose dated December 6, 2021 (Filed With SEC on December 10, 2021)
- Employment Agreement by and between Dermata Therapeutics, Inc. and Gerald T. Proehl dated December 6, 2021 (Filed With SEC on December 10, 2021)
- Consulting Agreement, dated September 1, 2021, between the Company and Thomas Insley (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the... (Filed With SEC on November 15, 2021)
- Consulting Agreement, dated September 1, 2021, between the Company and Thomas Insley (Filed With SEC on September 1, 2021)
- Amendment No. 1 to the Dermata Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on July 2, 2021)
- Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Maria Bedoya Toro Munera, Ph.D., M.B.A (Filed With SEC on June 10, 2021)
- Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Christopher J. Nardo, M.P.H., Ph.D (Filed With SEC on June 10, 2021)
- Form of Employment Agreement by and between Dermata Therapeutics, Inc. and Gerald T. Proehl (Filed With SEC on June 10, 2021)
- Form of Incentive Stock Option Award under 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)
- Form of Nonqualified Stock Option Award under 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)
- Dermata Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 10, 2021)
